Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of De Novo Sequencing
1.2 Key Market Segments
1.2.1 De Novo Sequencing Segment by Type
1.2.2 De Novo Sequencing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 De Novo Sequencing Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 De Novo Sequencing Market Competitive Landscape
3.1 Global De Novo Sequencing Revenue Market Share by Company (2019-2024)
3.2 De Novo Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company De Novo Sequencing Market Size Sites, Area Served, Product Type
3.4 De Novo Sequencing Market Competitive Situation and Trends
3.4.1 De Novo Sequencing Market Concentration Rate
3.4.2 Global 5 and 10 Largest De Novo Sequencing Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 De Novo Sequencing Value Chain Analysis
4.1 De Novo Sequencing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of De Novo Sequencing Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 De Novo Sequencing Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global De Novo Sequencing Market Size Market Share by Type (2019-2024)
6.3 Global De Novo Sequencing Market Size Growth Rate by Type (2019-2024)
7 De Novo Sequencing Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global De Novo Sequencing Market Size (M USD) by Application (2019-2024)
7.3 Global De Novo Sequencing Market Size Growth Rate by Application (2019-2024)
8 De Novo Sequencing Market Segmentation by Region
8.1 Global De Novo Sequencing Market Size by Region
8.1.1 Global De Novo Sequencing Market Size by Region
8.1.2 Global De Novo Sequencing Market Size Market Share by Region
8.2 North America
8.2.1 North America De Novo Sequencing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe De Novo Sequencing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific De Novo Sequencing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America De Novo Sequencing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa De Novo Sequencing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 10X Genomics Inc.
9.1.1 10X Genomics Inc. De Novo Sequencing Basic Information
9.1.2 10X Genomics Inc. De Novo Sequencing Product Overview
9.1.3 10X Genomics Inc. De Novo Sequencing Product Market Performance
9.1.4 10X Genomics Inc. De Novo Sequencing SWOT Analysis
9.1.5 10X Genomics Inc. Business Overview
9.1.6 10X Genomics Inc. Recent Developments
9.2 Abcam Plc
9.2.1 Abcam Plc De Novo Sequencing Basic Information
9.2.2 Abcam Plc De Novo Sequencing Product Overview
9.2.3 Abcam Plc De Novo Sequencing Product Market Performance
9.2.4 10X Genomics Inc. De Novo Sequencing SWOT Analysis
9.2.5 Abcam Plc Business Overview
9.2.6 Abcam Plc Recent Developments
9.3 Exeter Clinical Laboratory
9.3.1 Exeter Clinical Laboratory De Novo Sequencing Basic Information
9.3.2 Exeter Clinical Laboratory De Novo Sequencing Product Overview
9.3.3 Exeter Clinical Laboratory De Novo Sequencing Product Market Performance
9.3.4 10X Genomics Inc. De Novo Sequencing SWOT Analysis
9.3.5 Exeter Clinical Laboratory Business Overview
9.3.6 Exeter Clinical Laboratory Recent Developments
9.4 Psomagen
9.4.1 Psomagen De Novo Sequencing Basic Information
9.4.2 Psomagen De Novo Sequencing Product Overview
9.4.3 Psomagen De Novo Sequencing Product Market Performance
9.4.4 Psomagen Business Overview
9.4.5 Psomagen Recent Developments
9.5 BGI Genomics Co. Ltd.
9.5.1 BGI Genomics Co. Ltd. De Novo Sequencing Basic Information
9.5.2 BGI Genomics Co. Ltd. De Novo Sequencing Product Overview
9.5.3 BGI Genomics Co. Ltd. De Novo Sequencing Product Market Performance
9.5.4 BGI Genomics Co. Ltd. Business Overview
9.5.5 BGI Genomics Co. Ltd. Recent Developments
9.6 Bio Rad Laboratories Inc.
9.6.1 Bio Rad Laboratories Inc. De Novo Sequencing Basic Information
9.6.2 Bio Rad Laboratories Inc. De Novo Sequencing Product Overview
9.6.3 Bio Rad Laboratories Inc. De Novo Sequencing Product Market Performance
9.6.4 Bio Rad Laboratories Inc. Business Overview
9.6.5 Bio Rad Laboratories Inc. Recent Developments
9.7 Danaher Corp.
9.7.1 Danaher Corp. De Novo Sequencing Basic Information
9.7.2 Danaher Corp. De Novo Sequencing Product Overview
9.7.3 Danaher Corp. De Novo Sequencing Product Market Performance
9.7.4 Danaher Corp. Business Overview
9.7.5 Danaher Corp. Recent Developments
9.8 Eppendorf AG
9.8.1 Eppendorf AG De Novo Sequencing Basic Information
9.8.2 Eppendorf AG De Novo Sequencing Product Overview
9.8.3 Eppendorf AG De Novo Sequencing Product Market Performance
9.8.4 Eppendorf AG Business Overview
9.8.5 Eppendorf AG Recent Developments
9.9 Eurofins Scientific SE
9.9.1 Eurofins Scientific SE De Novo Sequencing Basic Information
9.9.2 Eurofins Scientific SE De Novo Sequencing Product Overview
9.9.3 Eurofins Scientific SE De Novo Sequencing Product Market Performance
9.9.4 Eurofins Scientific SE Business Overview
9.9.5 Eurofins Scientific SE Recent Developments
9.10 F. Hoffmann-La Roche Ltd.
9.10.1 F. Hoffmann-La Roche Ltd. De Novo Sequencing Basic Information
9.10.2 F. Hoffmann-La Roche Ltd. De Novo Sequencing Product Overview
9.10.3 F. Hoffmann-La Roche Ltd. De Novo Sequencing Product Market Performance
9.10.4 F. Hoffmann-La Roche Ltd. Business Overview
9.10.5 F. Hoffmann-La Roche Ltd. Recent Developments
9.11 CD Genomics
9.11.1 CD Genomics De Novo Sequencing Basic Information
9.11.2 CD Genomics De Novo Sequencing Product Overview
9.11.3 CD Genomics De Novo Sequencing Product Market Performance
9.11.4 CD Genomics Business Overview
9.11.5 CD Genomics Recent Developments
9.12 Illumina
9.12.1 Illumina De Novo Sequencing Basic Information
9.12.2 Illumina De Novo Sequencing Product Overview
9.12.3 Illumina De Novo Sequencing Product Market Performance
9.12.4 Illumina Business Overview
9.12.5 Illumina Recent Developments
9.13 qGenomics
9.13.1 qGenomics De Novo Sequencing Basic Information
9.13.2 qGenomics De Novo Sequencing Product Overview
9.13.3 qGenomics De Novo Sequencing Product Market Performance
9.13.4 qGenomics Business Overview
9.13.5 qGenomics Recent Developments
10 De Novo Sequencing Regional Market Forecast
10.1 Global De Novo Sequencing Market Size Forecast
10.2 Global De Novo Sequencing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe De Novo Sequencing Market Size Forecast by Country
10.2.3 Asia Pacific De Novo Sequencing Market Size Forecast by Region
10.2.4 South America De Novo Sequencing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of De Novo Sequencing by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global De Novo Sequencing Market Forecast by Type (2025-2030)
11.2 Global De Novo Sequencing Market Forecast by Application (2025-2030)
12 Conclusion and Key Findings
